Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT200 in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
CTR20181541Phase 2Completed
- Sponsor
- Sinocelltech Group Limited
- Start
- Sep 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of sct200 in head and neck squamous cell carcinoma (HNSCC), sponsored by Sinocelltech Group Limited. Started Sep 2018; status: completed.
02
Drugs
sct200
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on CTR20181541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181541.